# Nuo Therapeutics signs private label distribution deal with Smith+Nephew

Nuo Therapeutics has entered into an exclusive private label distribution agreement with Smith+Nephew for the CENTRIO Platelet-Rich Plasma System, a branded version of Nuo's Aurix System, for the US wound care market. Nuo will continue manufacturing the product.

- Type: Contract
- Announced: 2025-04-29
- Where: United States
- Status: completed
- Products: CENTRIO Platelet-Rich Plasma System, Aurix System
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Smith+Nephew](https://endata.com/companies/32105.md) (customer)
- [Nuo Therapeutics](https://endata.com/companies/84429.md) (supplier)

## Sources

- [streetinsider.com](https://www.streetinsider.com/Globe+Newswire/Nuo+Therapeutics+Announces+Exclusive+Private+Label+Distribution+Agreement+with+Smith%2BNephew/24708447.html), 2025-04-29: "This exclusive private label distribution agreement with Smith+Nephew is a significant development for Nuo."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.